Loading...

FITC anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-f11
C57BL/6 splenocytes stained with 30-F11 FITC
  • 30-f11
    C57BL/6 splenocytes stained with 30-F11 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103107 50 µg 36 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103108 500 µg 105 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Li Y, et al. 2020. Nat Commun. 2.350694444. PubMed
  2. Gabitova-Cornell L, et al. 2020. Cancer Cell. 38(4):567-583.e11. PubMed
  3. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  4. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  5. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  6. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  7. Shakya S, et al. 2020. MethodsX. 7:101027. PubMed
  8. Johnson DC, et al. 2018. Nat Med. 24:1151. PubMed
  9. Sefik E, et al. 2022. Nature. 606:585. PubMed
  10. Leinroth AP, et al. 2022. Cell Rep. 39:110785. PubMed
  11. Doughty D, et al. 2022. Exp Biol Med (Maywood). 247:1433. PubMed
  12. Du M, et al. 2022. Cancer Sci. 113:2974. PubMed
  13. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  14. Tao X, et al. 2022. EMBO J. 41:e110439. PubMed
  15. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  16. Li X, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:1077. PubMed
  17. Hindy G, et al. 2022. J Clin Invest. 132: . PubMed
  18. Roy IM, et al. 2022. iScience. 25:105171. PubMed
  19. Mendivil-Perez M, et al. 2022. Med Oncol. 40:15. PubMed
  20. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  21. Zheng Z, et al. 2022. Cells. 11: . PubMed
  22. Voit RA, et al. 2023. Nat Immunol. 24:69. PubMed
  23. Varshney R, et al. 2023. iScience. 26:105750. PubMed
  24. Cheng P, et al. 2023. Pharmacol Res. 188:106643. PubMed
  25. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  26. Chen L, et al. 2023. Bioeng Transl Med. 8:e10377. PubMed
  27. Stravokefalou V, et al. 2023. Front Immunol. 13:1014802. PubMed
  28. Zhao Y, et al. 2023. Sci Adv. 9:eabo1360. PubMed
  29. Liu X, et al. 2022. Pain. 163:508. PubMed
  30. González H, et al. 2022. Cell. 185:729. PubMed
  31. Mecklenburg J, et al. 2022. Brain Behav Immun. 101:246. PubMed
  32. Na E, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L550. PubMed
  33. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  34. Ajay AK, et al. 2022. Cell Rep. 38:110473. PubMed
  35. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  36. Pfeifhofer-Obermair C, et al. 2022. Bio Protoc. 12:e4378. PubMed
  37. Hanuscheck N, et al. 2022. J Exp Med. 219:. PubMed
  38. Klawitter M, et al. 2022. Int J Mol Sci. 23:. PubMed
  39. Zheng Y, et al. 2022. Proc Natl Acad Sci U S A. 119:e2121077119. PubMed
  40. Bowley TY, et al. 2022. Cancer Res Commun. 2:1436. PubMed
  41. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  42. Zhang Y, et al. 2023. Invest Ophthalmol Vis Sci. 64:1. PubMed
  43. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  44. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  45. Li M, et al. 2023. Front Immunol. 14:1087923. PubMed
  46. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  47. Ferriz M, et al. 2023. STAR Protoc. 4:102079. PubMed
  48. Volkova MV, et al. 2023. Int J Mol Sci. 24:. PubMed
  49. Solier S, et al. 2023. Int J Mol Sci. 24:. PubMed
  50. Li L, et al. 2023. iScience. 26:106095. PubMed
  51. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  52. Xu H, et al. 2023. Acta Pharm Sin B. 13:678. PubMed
  53. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  54. Rege SV, et al. 2023. Commun Biol. 6:292. PubMed
  55. Wang Y, et al. 2023. J Nanobiotechnology. 21:109. PubMed
  56. Zhang X, et al. 2023. Front Immunol. 14:1116749. PubMed
  57. Kim BH, et al. 2023. Sci Rep. 13:6577. PubMed
  58. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  59. Kase N, et al. 2023. Front Cell Dev Biol. 11:1022081. PubMed
  60. Huang T, et al. 2023. Cell Death Dis. 14:354. PubMed
  61. Guo X, et al. 2023. Mol Immunol. 160:32. PubMed
  62. Wang X, et al. 2023. Nature. 618:808. PubMed
  63. Akasaka H, et al. 2023. JCI Insight. 8:. PubMed
  64. Nederlof R, et al. 2022. Front Immunol. 13:908023. PubMed
  65. Kataru RP, et al. 2021. Sci Signal. 14:. PubMed
  66. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  67. J Gautam, X Zhang, Y Yao 2016. Sci Rep. 6:36450. PubMed
  68. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  69. McGill BE et al. 2018. The Journal of Neuroscience. 38(1):200-219 . PubMed
  70. Hofmann I, et al. 2022. J Pharmacol Exp Ther. Online ahead of print. PubMed
  71. Hulsebus HJ, et al. 2022. Front Immunol. 13:884719. PubMed
  72. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  73. El-Hindi K, et al. 2022. Int J Mol Sci. 23:. PubMed
  74. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  75. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  76. Sharma GP, et al. 2021. PLoS One. 16:e0259042. PubMed
  77. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  78. Tcheng M, et al. 2021. Blood. 137:3518. PubMed
  79. Zhu H, et al. 2018. Elife. 7:. PubMed
  80. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  81. Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed
  82. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  83. Wang M, et al. 2022. Theranostics. 12:4513. PubMed
  84. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  85. Abdala-Valencia H, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:482. PubMed
  86. Saito S, et al. 2020. Nutrients. 12:. PubMed
  87. Liu X, et al. 2020. Nature. . PubMed
  88. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  89. Shao Y, et al. 2019. Diabetes. 68:2131. PubMed
  90. Lee AK, et al. 2020. Radiat Res. 193:305. PubMed
  91. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  92. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  93. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  94. Pan D, et al. 2022. Cancer Res. 82:2748. PubMed
  95. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  96. Zhao G, et al. 2020. Sci Adv. 6:00. PubMed
  97. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  98. Wosczyna MN, et al. 2021. Cell Stem Cell. 28(7):1323-1334.e8. PubMed
  99. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  100. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  101. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  102. Ohigashi I, et al. 2020. Cell Reports. 29(9):2901-2916.e6.. PubMed
  103. Zhang Q, et al. 2019. PLoS Biol. 17:e3000330. PubMed
  104. Ihara S, et al. 2022. PLoS Negl Trop Dis. 16:e0010323. PubMed
  105. Talma N, et al. 2021. Aging Cell. 20:e13450. PubMed
  106. Rolfes S, et al. 2020. Neurobiol Dis. 144:105024. PubMed
  107. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  108. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  109. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  110. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  111. Meixiong J et al. 2019. Immunity. 50(5):1163-1171 . PubMed
  112. Xiao X, et al. 2019. Cell Discov. 5:2. PubMed
  113. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  114. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  115. Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed
  116. Kucinski I, et al. 2020. EMBO J. :e104983. PubMed
  117. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  118. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  119. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  120. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  121. Hore ZL, et al. 2021. Wellcome Open Res. 6:68. PubMed
  122. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  123. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  124. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  125. Feng Y, et al. 2018. Kidney Dis (Basel). 4:95. PubMed
  126. Wosczyna MN et al. 2019. Cell Rep. 27(7):2029-2035 . PubMed
  127. Plein A, et al. 2018. Nature. 562:223. PubMed
  128. Kobayashi S, et al. 2019. J Immunol. 203:1447. PubMed
  129. Green DP, et al. 2019. Neuron. 101:412. PubMed
  130. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  131. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  132. Koujah L, et al. 2021. Ocul Surf. 21:238. PubMed
  133. Kumari A, et al. 2022. Sci Rep. 12:15273. PubMed
  134. Li P, et al. 2021. Nat Immunol. 22:1107. PubMed
  135. Zhang X, et al. 2022. Cells. 11:. PubMed
  136. Kusuyama J, et al. 2021. Cell Metabolism. 33(5):939-956.e8. PubMed
  137. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  138. Barman PK, et al. 2019. J Immunol. 202:2720. PubMed
  139. Lim D, et al. 2018. Front Physiol. 9:47. PubMed
  140. Zein HS, et al. 2022. Sci Rep. 12:4834. PubMed
  141. Luo W, et al. 2022. Front Immunol. 13:816761. PubMed
  142. Hu J, et al. 2020. Theranostics. 7.154166667. PubMed
  143. Li J, et al. 2020. Elife. 9:00. PubMed
  144. Rosa JM, et al. 2021. British Journal of Pharmacology. . PubMed
  145. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  146. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  147. Poillet-Perez L, et al. 2020. Nat Cancer. 1:923. PubMed
  148. Cervera–Carrascon V, et al. 2020. Oncoimmunology. 9:1761229. PubMed
  149. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  150. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  151. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  152. Gañán-Gómez I, et al. 2022. Nat Med. . PubMed
  153. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  154. Zhang K, et al. 2014. PLoS Pathog. 10:1004385. PubMed
  155. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  156. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  157. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  158. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  159. Nguyen PT, et al. 2020. Cell. 182(2):388-403.e15. PubMed
  160. Liu CY, et al. 2020. Cell Rep. 33:108275. PubMed
  161. Wan X, et al. 2018. Nature. 560:107. PubMed
  162. Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed
  163. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  164. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  165. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  166. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  167. Watanabe Y, et al. 2020. J Biol Chem. 295:17632. PubMed
  168. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  169. Ruan C, et al. 2020. Brain Behav Immun. 83:180. PubMed
  170. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  171. Wang F, et al. 2019. MAbs. 12:1685350. PubMed
  172. Ji DX, et al. 2019. Nat Microbiol. 1.644444444. PubMed
  173. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  174. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  175. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  176. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  177. Maetzig T, et al. 2017. Mol Ther. 25:606. PubMed
  178. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
  179. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  180. Agelidis A, et al. 2021. JCI Insight. 6: . PubMed
  181. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  182. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  183. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  184. Pundir P, et al. 2020. Cell Host & Microbe. 26(1):114-122. PubMed
  185. Gastelum‐Aviña P et al. 2016. Journal of immunological methods. 438:42-50 . PubMed
  186. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  187. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  188. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  189. Milner MT, et al. 2022. STAR Protoc. 3:101295. PubMed
  190. Zhang X, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  191. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  192. Kotas ME, et al. 2022. JCI Insight. :. PubMed
  193. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  194. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  195. Jiang Q, et al. 2020. JCI Insight. 5:00. PubMed
  196. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
  197. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  198. Li CM, et al. 2020. Cell Reports. 33(13):108566. PubMed
  199. Zhang L, et al. 2021. iScience. 24(9):102942. PubMed
  200. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  201. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  202. Sarvi S et al. 2018. Cell chemical biology. 25(12):1456-1469 . PubMed
  203. Sirvinskas D, et al. 2022. iScience. 25:104202. PubMed
  204. Minhas PS, et al. 2021. Nature. 590:122. PubMed
  205. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  206. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  207. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  208. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  209. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  210. Long JT, et al. 2022. Elife. 11:. PubMed
  211. Bravo-Caparrós I, et al. 2020. FASEB J. 34:5951. PubMed
  212. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  213. Ito K, et al. 2014. Proc Natl Acad Sci U S A. 111:3080. PubMed
  214. Saunders L, et al. 2015. Sci Transl Med. 7: 302ra136. PubMed
  215. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  216. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  217. Kim H, et al. 2020. Biomed Rep. 0.589583333. PubMed
  218. Qi F, et al. 2019. Front Microbiol. 2.140277778. PubMed
  219. Yu JM, et al. 2019. Nat Commun. 4.388888889. PubMed
  220. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  221. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  222. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  223. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  224. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  225. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  226. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  227. Ovadya Y, et al. 2018. Nat Commun. 9:5435. PubMed
  228. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  229. Ferrer-Font L, et al. 2020. Elife. 9:. PubMed
  230. Sakai H, et al. 2022. iScience. 25:103928. PubMed
  231. Walker MT, et al. 2021. Front. Allergy. 2:. PubMed
  232. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  233. Pan Y, et al. 2021. Br J Pharmacol. 178:4907. PubMed
  234. Okada R, et al. 2021. EBioMedicine. 67:103345. PubMed
  235. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  236. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  237. Liu L et al. 2018. Cell stem cell. 23(4):544-556 . PubMed
  238. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  239. Hameed H, et al. 2022. Int J Mol Sci. 23:. PubMed
  240. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  241. Liu R, et al. 2020. Eur J Vasc Endovasc Surg. 60:254. PubMed
  242. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  243. Simoes Eugénio M, et al. 2020. Cancers (Basel). 12:00. PubMed
  244. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  245. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  246. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  247. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  248. Krivtsov AV, et al. 2020. Cancer Cell. 36(6):660-673.e11.. PubMed
  249. Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed
  250. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  251. Hao T, et al. 2019. Nat Commun. 10:3665. PubMed
  252. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  253. Banskota S, et al. 2021. Inflamm Bowel Dis. 27:914. PubMed
  254. Ruan Y, et al. 2022. Exp Ther Med. 23:47. PubMed
  255. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  256. Liao X, et al. 2022. JCI Insight. 7:. PubMed
  257. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  258. Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
  259. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  260. Watanabe Y, et al. 2020. J Biol Chem. . PubMed
  261. Sheng J, et al. 2021. eLife. 10:00. PubMed
  262. Tr änkner D, et al. 2019. Cell Rep. 29:791. PubMed
  263. Lee C, et al. 2020. Front Immunol. 11:77. PubMed
  264. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  265. Poillet–Perez L, et al. 2018. Nature. 563:569. PubMed
  266. Padhye A, et al. 2019. Sci Rep. 9:4819. PubMed
  267. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  268. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  269. El-Obeid A, et al. 2021. Exp Ther Med. 22:1081. PubMed
  270. Li M, et al. 2020. Nat Commun. 4051:11. PubMed
  271. Shao Y, et al. 2019. Stem Cells. 37:1331. PubMed
  272. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  273. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  274. Le TM et al. 2018. Journal of neurochemistry. 145(2):139-153 . PubMed
  275. Lee EKS, et al. 2018. Cell Host Microbe. 23:121. PubMed
  276. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  277. Andreata F, et al. 2021. STAR Protoc. 2:100831. PubMed
  278. Ichinose M, et al. 2021. Sci Rep. 7200:11. PubMed
  279. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  280. Dingler FA, et al. 2020. Mol Cell. . PubMed
  281. Wan Y, et al. 2020. Cell Rep. 33:108346. PubMed
  282. Badgujar DC, et al. 2020. PLoS Pathog. 16:e1009016. PubMed
  283. Ma Y, et al. 2020. Front Immunol. 11:586685. PubMed
  284. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  285. Guarnerio J, et al. 2018. Nat Commun. 9:66. PubMed
  286. Wolf Y, et al. 2019. Cell. 179:219. PubMed
  287. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  288. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  289. Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed
  290. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
RRID
AB_312972 (BioLegend Cat. No. 103107)
AB_312973 (BioLegend Cat. No. 103108)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
Go To Top Version: 2    Revision Date: 05.14.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account